FOSTER CITY, CA--(Marketwire - December 02, 2008) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Gary Titus as Chief Financial Officer and Senior Vice President, Finance, effective December 8, 2008. In this position, Mr. Titus will use his significant biotechnology industry experience to lead finance activities and investor relations for the Company as well as oversee human resources, and legal affairs. Mr. Titus will report to Friedhelm Blobel, Ph.D., President and Chief Executive Officer of SciClone.
